Suppr超能文献

苯二氮䓬受体配体CGS 9895对啮齿动物的地西泮拮抗作用差异

Differential diazepam-antagonist effects of the benzodiazepine receptor ligand CGS 9895 in rodents.

作者信息

Katzman N J, Shannon H E

出版信息

J Pharmacol Exp Ther. 1985 Dec;235(3):589-95.

PMID:3001268
Abstract

CGS 9895, a pyrazoloquinolone benzodiazepine receptor ligand, was administered alone and concomitantly with diazepam in order to assess its agonist and diazepam-antagonist properties on various behaviors in rodents. In mice, CGS 9895 neither potentiated nor blocked the convulsant effects of pentylenetetrazole. However, doses of 3.0 and 10 mg/kg of CGS 9895 i.p. produced dose-related antagonism of the anticonvulsant effects of diazepam against pentylenetetrazole (80 mg/kg i.p.). In rats, diazepam produced dose-related increases in ataxia as measured on the rotarod. CGS 9895 (0.3-10 mg/kg i.p.) was without effect on performance on the rotarod, but produced dose-related parallel shifts to the right in the diazepam dose-effect curve. Also in rats, behavior was maintained under a multiple schedule where in one component every 20th response resulted in water presentation (unpunished behavior) and in a second component every 20th response resulted in both shock and water presentation (punished behavior). CGS 9895 (0.3-30 mg/kg i.p.) was without significant effect on either punished or unpunished responding. Increasing doses of diazepam (0.1-10 mg/kg p.o.) first increased and then decreased rates of punished responding but only decreased rates of unpunished responding. CGS 9895 (3.0 mg/kg i.p.) neither potentiated nor antagonized diazepam. In another group of rats, behavior was maintained under a multiple fixed-interval 5 min fixed-ratio 20 response schedule of water presentation. CGS 9895 (0.3-30 mg/kg i.p.) did not affect performance under this schedule. Diazepam (0.3-30 mg/kg p.o.) primarily decreased rates under the fixed-ratio schedule, but increasing doses first increased and then decreased rates under the fixed-interval schedule.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

CGS 9895是一种吡唑并喹啉酮类苯二氮䓬受体配体,单独给药并与地西泮联合给药,以评估其对啮齿动物各种行为的激动剂和地西泮拮抗剂特性。在小鼠中,CGS 9895既不增强也不阻断戊四氮的惊厥作用。然而,腹腔注射3.0和10mg/kg的CGS 9895可产生与剂量相关的对戊四氮(腹腔注射80mg/kg)的地西泮抗惊厥作用的拮抗作用。在大鼠中,地西泮使旋转棒上测量的共济失调呈剂量相关增加。CGS 9895(腹腔注射0.3 - 10mg/kg)对旋转棒上的表现无影响,但在地西泮剂量效应曲线中产生与剂量相关的平行右移。同样在大鼠中,行为在多重时间表下维持,其中在一个成分中每20次反应导致给予水(无惩罚行为),在第二个成分中每20次反应导致给予电击和水(惩罚行为)。CGS 9895(腹腔注射0.3 - 30mg/kg)对惩罚或无惩罚反应均无显著影响。地西泮剂量增加(口服0.1 - 10mg/kg)首先增加然后降低惩罚反应率,但仅降低无惩罚反应率。CGS 9895(腹腔注射3.0mg/kg)既不增强也不拮抗地西泮。在另一组大鼠中,行为在多重固定间隔5分钟固定比率20次反应的给水时间表下维持。CGS 9895(腹腔注射0.3 - 30mg/kg)在此时间表下不影响表现。地西泮(口服0.3 - 30mg/kg)主要降低固定比率时间表下的反应率,但增加剂量首先增加然后降低固定间隔时间表下反应率。(摘要截断于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验